NRAS c.296A>T ;(p.Q99L)

Variant ID: 1-115252344-T-A

NM_002524.4(NRAS):c.296A>T;(p.Q99L)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53.

Cancer Medicine
Gao, Fan F; Hu, Kai K; Zheng, Peihao P; Shi, Hui H; Ke, Xiaoyan X
Publication Date: 2023-03-27

Variant appearance in text: NRAS: 296A>T; Q99L
PubMed Link: 36971051
Variant Present in the following documents:
  • CAM4-12-10267-s001.xlsx, sheet 1
View BVdb publication page



Genetic landscapes and curative effect of CAR T-cell immunotherapy in relapse and refractory DLBCL patients.

Blood Advances
Shi, Hui H; Zheng, Peihao P; Liu, Rui R; Xu, Teng T; Yang, Fan F; Feng, Shaomei S; Guo, Yuelu Y; Ma, Lixia L; Liu, Haidi H; Lei, Yang Y; Li, Ruiting R; Deng, Biping B; Hou, Shuling S; Li, Yang Y; Zheng, Qinlong Q; Hu, Kai K; Ke, Xiaoyan X
Publication Date: 2022-07-28

Variant appearance in text: NRAS: 296A>T; Q99L
PubMed Link: 35901280
Variant Present in the following documents:
  • BLOODA_ADV-2021-006845-mmc1.xlsx, sheet 2
View BVdb publication page



Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.

Frontiers In Genetics
Gao, Fan F; Tian, Lei L; Shi, Hui H; Zheng, Peihao P; Wang, Jing J; Dong, Fei F; Hu, Kai K; Ke, Xiaoyan X
Publication Date: 2021

Variant appearance in text: NRAS: 296A>T; Q99L
PubMed Link: 34925435
Variant Present in the following documents:
  • DataSheet2.xlsx, sheet 1
View BVdb publication page



Mefatinib as first-line treatment of patients with advanced EGFR-mutant non-small-cell lung cancer: a phase Ib/II efficacy and biomarker study.

Signal Transduction And Targeted Therapy
Wang, Pingli P; Li, Yuping Y; Lv, Dongqing D; Yang, Lingge L; Ding, Liren L; Zhou, Jianya J; Hong, Wei W; Chen, Youfei Y; Zhang, Dongqing D; He, Susu S; Zhou, Jianying J; Wang, Kai K
Publication Date: 2021-11-01

Variant appearance in text: NRAS: Q99L
PubMed Link: 34719670
Variant Present in the following documents:
  • 41392_2021_773_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance.

Nature Communications
Li, Shun S; Song, Ying Y; Quach, Christine C; Guo, Hongrui H; Jang, Gyu-Beom GB; Maazi, Hadi H; Zhao, Shihui S; Sands, Nathaniel A NA; Liu, Qingsong Q; In, Gino K GK; Peng, David D; Yuan, Weiming W; Machida, Keigo K; Yu, Min M; Akbari, Omid O; Hagiya, Ashley A; Yang, Yongfei Y; Punj, Vasu V; Tang, Liling L; Liang, Chengyu C
Publication Date: 2019-04-12

Variant appearance in text: NRAS: Q99L
PubMed Link: 30979895
Variant Present in the following documents:
  • Main text
  • 41467_2019_9634_MOESM2_ESM.pdf
View BVdb publication page